Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Urinary markers/cytology: what and when should a urologist use.

Tomasini JM, Konety BR.

Urol Clin North Am. 2013 May;40(2):165-73. doi: 10.1016/j.ucl.2013.01.015. Epub 2013 Mar 1. Review.

PMID:
23540775
2.

Current and emerging bladder cancer urinary biomarkers.

Parker J, Spiess PE.

ScientificWorldJournal. 2011 May 26;11:1103-12. doi: 10.1100/tsw.2011.104. Review.

3.

Non-invasive diagnostic tests for bladder cancer: a review of the literature.

Bassi P, De Marco V, De Lisa A, Mancini M, Pinto F, Bertoloni R, Longo F.

Urol Int. 2005;75(3):193-200. Review.

PMID:
16215303
4.

Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.

Herman MP, Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF.

Minerva Urol Nefrol. 2008 Dec;60(4):217-35. Review.

PMID:
18923359
5.

Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.

Kehinde EO, Al-Mulla F, Kapila K, Anim JT.

Scand J Urol Nephrol. 2011 Mar;45(2):113-21. doi: 10.3109/00365599.2010.533694. Epub 2010 Nov 22.

PMID:
21091091
6.

Telomerase and other novel approaches to bladder cancer detection.

Bennett A.

Clin Lab Sci. 2008 Summer;21(3):185-90; quiz 191-2, following 192. Review.

PMID:
18678141
7.

Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.

Lekili M, Sener E, Demir MA, Temeltaş G, Müezzinoğlu T, Büyüksu C.

Urol Res. 2004 May;32(2):124-8. Epub 2003 Dec 19.

PMID:
14685796
8.

Screening for bladder cancer using urine-based tumor markers.

Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF.

Minerva Urol Nefrol. 2008 Dec;60(4):247-53. Review.

PMID:
18923361
9.

NMP-22, urinary cytology, and cystoscopy: a 1 year comparison study.

Schlake A, Crispen PL, Cap AP, Atkinson T, Davenport D, Preston DM.

Can J Urol. 2012 Aug;19(4):6345-50.

PMID:
22892257
10.

Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.

Calistri D, Casadio V, Bravaccini S, Zoli W, Amadori D.

Expert Rev Anticancer Ther. 2012 Jun;12(6):743-52. doi: 10.1586/era.12.50.

PMID:
22716491
11.

Urine cytology. It is still the gold standard for screening?

Brown FM.

Urol Clin North Am. 2000 Feb;27(1):25-37. Review.

PMID:
10696242
12.

UPK3A: a promising novel urinary marker for the detection of bladder cancer.

Lai Y, Ye J, Chen J, Zhang L, Wasi L, He Z, Zhou L, Li H, Yan Q, Gui Y, Cai Z, Wang X, Guan Z.

Urology. 2010 Aug;76(2):514.e6-11. doi: 10.1016/j.urology.2009.11.045. Epub 2010 Mar 25.

PMID:
20346489
13.

Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.

Kumar A, Kumar R, Gupta NP.

Jpn J Clin Oncol. 2006 Mar;36(3):172-5. Epub 2006 Mar 6.

14.

Bladder tumor markers: a review of the literature.

Volpe A, Racioppi M, D'Agostino D, Cappa E, Gardi M, Totaro A, Pinto F, Sacco E, Marangi F, Palermo G, Bassi PF.

Int J Biol Markers. 2008 Oct-Dec;23(4):249-61. Review.

PMID:
19199274
15.

[Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations].

Fukui Y, Samma S, Fujimoto K, Akiyama T, Yamaguchi A, Hirayama A.

Hinyokika Kiyo. 2001 May;47(5):311-4. Japanese.

PMID:
11433750
16.

Urine based markers of urological malignancy.

Konety BR, Getzenberg RH.

J Urol. 2001 Feb;165(2):600-11. Review.

PMID:
11176445
17.

[Bladder cancer biomarkers].

Dobrowolska-Glazar B, Glazar W, Dobrowolski Z, Lipczyński W.

Przegl Lek. 2010;67(7):479-83. Review. Polish.

PMID:
21387760
18.

Comparison of cytology and nuclear matrix protein 22 (NMP 22) for the detection and follow-up of bladder-cancer.

Lahme S, Bichler KH, Feil G, Zumbrägel A, Götz T.

Adv Exp Med Biol. 2003;539(Pt A):111-9.

PMID:
15088900
19.

Urinary markers of bladder carcinoma.

Dey P.

Clin Chim Acta. 2004 Feb;340(1-2):57-65. Review.

PMID:
14734196
20.

Role of NMP22 Bladder Check Test in early detection of bladder cancer with recurrence.

Kundal VK, Pandith AA, Hamid A, Shah A, Kundal R, Wani SM.

Asian Pac J Cancer Prev. 2010;11(5):1279-82.

Items per page

Supplemental Content

Write to the Help Desk